Skip to content

Microthin-Pii Bipolar Pulse Gen. #0621

by Cardiac Pacemakers, Inc.

510(k) K803035

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK803035 Date22 Dec 1980ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
DXY
Device Class
Class III
Regulation
21 CFR Part 870.3610
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Microthin-PII Bipolar Pulse Generator #0621 is an Implantable Pacemaker Pulse-Generator, a Class III medical device designed to regulate cardiac rhythm by delivering electrical impulses to the heart. It is intended for patients requiring artificial pacing to correct bradycardia or other conduction disorders, ensuring consistent and reliable cardiac output through programmable pacing parameters.

This device is supplied as a reusable, implantable unit and is intended for use in clinical settings by trained healthcare professionals. It is not MRI-safe and must be handled according to sterile procedures prior to implantation. The device is authorised under FDA 510K clearance (K803035) and falls under regulation 870.3610, with a decision classification of Substantially Equivalent to a predicate device. Storage and handling must comply with manufacturer guidelines to maintain functionality and sterility.

Other devices from Cardiac Pacemakers, Inc.

See all devices from Cardiac Pacemakers, Inc. →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What clinical conditions is the Microthin-PII Bipolar Pulse Generator intended to treat?

    The Microthin-PII Bipolar Pulse Generator is designed to regulate cardiac rhythm for patients with bradycardia or conduction disorders by delivering programmable electrical impulses to the heart. It ensures consistent cardiac output, which is critical for maintaining stable heart function in patients requiring artificial pacing.

  • Is this device intended for single-use or can it be reused after implantation?

    The Microthin-PII Bipolar Pulse Generator is supplied as a reusable, implantable unit. It is intended for long-term use within patients and must be handled according to sterile procedures prior to implantation, as it is not designed for single-use.

  • What storage and handling precautions should be taken for this device?

    The device must be stored and handled in compliance with the manufacturer’s guidelines to maintain its functionality and sterility. Since it is implantable and requires sterile procedures before use, proper storage conditions are essential to prevent contamination or damage.

  • Is this device compatible with MRI procedures?

    No, the Microthin-PII Bipolar Pulse Generator is explicitly stated as *not* MRI-safe. This means it should not be exposed to MRI environments, as the magnetic fields could interfere with its operation or cause harm to the patient.

  • What regulatory pathway was followed for this device’s approval, and what does that mean for its safety and equivalence?

    The device was cleared through the FDA’s 510(k) process (K803035) under a *Traditional* review pathway, with a decision classification of *Substantially Equivalent* to a predicate device. This means it was determined to have the same intended use and technological characteristics as a previously approved device, ensuring its safety and effectiveness are supported by prior regulatory findings.